Epicyt Pharma reports positive results in first-in-human study of BAFA in patients following gastric bypass surgery

Contributed by: PR Newswire

Tags

Epicyt-Pharma-AB

More Like This

Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™

Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process

Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success

BariaTek Medical Announces the First-in-Human Implantation of Its BariTon™ Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Invasiveness

Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

Implantica announces new exceptional published data from the largest real-world study from Germany

Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia